Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Debt / NOTE 4.000% 4/0
-
Number of holders
-
6
-
Total 13F principal, excl. options
-
85.3M
-
Principal change
-
-7.43M
-
Total reported value, excl. options
-
$97.4M
-
Value change
-
+$718K
-
Number of buys
-
2
-
Number of sells
-
-5
-
Price
-
$0.85
Significant Holders of TRINITY BIOTECH INVT LTD - NOTE 4.000% 4/0 as of Q4 2016
10 filings reported holding 89643QAB4 - TRINITY BIOTECH INVT LTD - NOTE 4.000% 4/0 as of Q4 2016.
TRINITY BIOTECH INVT LTD - NOTE 4.000% 4/0 has 6 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of $85.3M of principal
.
Largest 10 bondholders include DEERFIELD MANAGEMENT CO ($48M of principal), HIGHBRIDGE CAPITAL MANAGEMENT LLC ($23.9M of principal), Linden Advisors LP ($8.59M of principal), CITADEL ADVISORS LLC ($4M of principal), PALISADE CAPITAL MANAGEMENT LLC/NJ ($850K of principal), Wellesley Asset Management ($29.7K of principal), Park West Asset Management LLC ($0 of principal), GABELLI FUNDS LLC ($0 of principal), WOLVERINE ASSET MANAGEMENT LLC ($0 of principal), and Pine River Capital Management L.P. ($0 of principal).
This table shows the top 6 institutional bondholders of the company debt. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.